• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Shine Medical Technologies

Shine Medical Technologies debuts therapeutics division

October 16, 2019 By Brad Perriello

Medical isotopes maker Shine Medical Technologies last week created a division to make therapeutic products, saying it plans to first focus on a cancer treatment. The Janesville, Wis.-based company said its Shine Therapeutics business will begin with the development and commercialization of lutetium-177, an isotope that can be combined with a disease-targeting molecule, for treating […]

Filed Under: Featured, Radiosurgery/Radiation therapy, Research & Development Tagged With: Shine Medical Technologies

Isotope maker Shine Medical raises $50m from Oaktree Capital

October 9, 2019 By Sean Whooley

Shine Medical Technologies said this week that it closed a $50 million financing round from Oaktree Capital Management for the construction of a medical isotope production facility and commercialization of its products. The Janesville, Wis.-based company expects construction on the plant to be completed in 2021, with commercial-scale isotope production slated to begin the following […]

Filed Under: Funding Roundup, Radiosurgery/Radiation therapy Tagged With: Shine Medical Technologies

Innoblative taps ex-Lumicell chief Londy for CEO | Personnel Moves, Sept. 13, 2019

September 13, 2019 By Brad Perriello

Innoblative Designs last week named former Lumicell chief executive Kelly Londy as its new CEO. Apart from her two-year stint at the Lumicell helm, Londy was COO at Accuray (NSDQ:ARAY) and worked at GE Healthcare and Philips Healthcare. “Innoblative’s Sira RF ablation device offers unique capabilities that address shortcomings in the current advanced energy surgical market,” […]

Filed Under: Business/Financial News, Featured Tagged With: Alpha Tau Medical, Cala Health, Genetesis, Innoblative Designs, IRRAS, MiMedx Group Inc., Obalon Therapeutics, Orchestra BioMed, Ozop Surgical, Personnel Moves, Shine Medical Technologies

Shine Medical adds $18m

July 1, 2019 By Brad Perriello

Shine Medical Technologies said last week that it raised another $18 million for the medical radioisotopes it makes. Janesville, Wis.-based Shine Medical said the equity, options and warrants round logged its first sale April 26 and has a total goal of $30 million. Some 99 unnamed investors participated in the $18.1 million round, according to […]

Filed Under: Featured, Funding Roundup, Imaging, Wall Street Beat Tagged With: Shine Medical Technologies

U of Missouri becomes first to ship isotope for thyroid cancer in U.S.

November 9, 2018 By Nancy Crotti

The University of Missouri Research Reactor (MURR) recently shipped its first batch of a medical isotope used to diagnose and treat thyroid cancer, making it the first domestic source of Iodine-131 (I-131) in 30 years. I-131 has only an eight-day half-life, making stockpiling impossible, and demand is expected to increase. Thyroid cancer is “the most rapidly increasing […]

Filed Under: Diagnostics, Featured, Oncology Tagged With: internationalisotopesinc., Shine Medical Technologies, University of Missouri

ARTMS’ system may ease cost, shortage of valuable radioisotopes

August 8, 2018 By Nancy Crotti

ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class, advanced technology Quantm irradiation system, designed to produce high-value medical imaging isotopes such as technetium-99m (Tc-99m) on medical cyclotrons. Tc-99m is given to nearly 50,000 Americans every day to diagnose cancer and heart disease. It is used in more than 80% of all nuclear […]

Filed Under: Diagnostics, Imaging, Neurological, Oncology, Regulatory/Compliance, Urology Tagged With: artms, CE Mark, Shine Medical Technologies

Medical tracer dev Shine Medical Tech raises $30m

April 4, 2017 By Fink Densford

Shine Medical Technologies raised $29.3 million in a new round of debt and option financing, according to an SEC filing posted this week. Shine Medical is a development-stage company working towards becoming a radioisotope manufacturer, according to the company’s website. The company touts that its proposed production technologies do not require a nuclear reactor, use […]

Filed Under: Business/Financial News, Imaging Tagged With: Shine Medical Technologies

Medical isotope producer Shine Medical raises $27.2m

January 17, 2017 By Sarah Faulkner

Shine Medical Technologies said last week in an SEC filing that it raised $27.2 million in a round of debt financing. Over 200 investors have contributed to the $29 million offering, which made its 1st sale on October 11, 2013. Monona, Wis.-based Shine Medical makes radioactive isotopes for medical diagnostic purposes such as detecting and treating cancer, according to the […]

Filed Under: Cardiovascular, Diagnostics, Funding Roundup, Oncology Tagged With: Shine Medical Technologies

NRC OKs Shine Medical isotope plant

February 25, 2016 By Fink Densford

Shine Medical Technologies said today it won clearance from the U.S. Nuclear Regulatory Commission to construct a medical isotope manufacturing facility. Shine Medical said the company is the only U.S. medical isotope producer to have reached this permission stage with the NRC since 1960 for the 57,000 square foot facility in Janesville, Wisc. “This is the […]

Filed Under: Business/Financial News, Oncology Tagged With: Shine Medical Technologies

Medical isotope maker Shine Medical raises $11.5m

January 8, 2016 By Fink Densford

Shine Medical raised $11.5 million in a new round of debt financing, according to an SEC filing posted today. Monona, Wis.-based Shine Medical produces radioactive isotopes for medical applications such as detecting and treating heart disease and cancer, according to the company’s website. The company’s main product is Molybdenum -99, which is used in Technetium-99m […]

Filed Under: Business/Financial News, Oncology Tagged With: Shine Medical Technologies

Imaging agent maker Shine Medical raises $11M | Wall Street Beat

October 19, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Shine Medical closed an $11.4 million funding round for its method of generating a low-energy neutron source for medical imaging that uses a particle accelerator instead of a nuclear reactor.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Baxter, Danaher Corp., NxStage Medical Inc., PricewaterhouseCoopers (PwC), Shine Medical Technologies

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS